Prognosis Implication of a Novel Metabolism-Related Gene Signature in Ewing Sarcoma

Figure 5

The efficiency of the MTG signature for prognosis of different subgroups in the GEO cohort. K-M survival analysis for the low- and high-risk groups categorized by clinical variables, comprising age (a, b), metastasis (c), primary tumor (d), recurrence (e), and gender (f, g).

(a)

(b)

(c)

(d)

(e)

(f)

(g)